A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
9/22/2026
GlaucomaIOLNewsletterRefractiveRetina
Ophthalmologists Report 5.4 Percent Decrease in Q2-2026 Procedure Volume
US ophthalmologists reported that ophthalmic procedures decreased 5.4 percent in Q2-2026 compared with the same quarter in 2025, according to Market Scope’s latest survey. Year-over-year performanc...
9/22/2026
EarningsNewsletterRevenue
Ophthalmic Company Revenue Drops 0.8 Percent in Second Quarter of 2026
Ophthalmic manufacturer revenue in Q2-2026 totaled $11.8 billion. Revenue decreased 0.8 percent from the same quarter in 2025 and increased 3.3 percent from Q1-2026. The total includes Market Scope...
9/22/2026
AIDiagnosticDigitalNewsletter
Future of Ophthalmic Diagnostic Innovation May Hinge on Integration, Reliability
Manufacturers have invested heavily in AI, cloud connectivity, and digital applications over the past several years. These developments are continuing, but AI and digitalization are becoming less d...
9/22/2026
Cell TherapyGene TherapyNewsletterRetina
New IRD Therapies Could Shake Up Nonexudative Retinal Pharma Market
Complement inhibitors reaped more than three-quarters of manufacturers’ revenue in the nonexudative retinal pharmaceuticals market in 2025, but candidates for inherited retinal diseases (IRD) are g...
9/22/2026
Dry EyeNewsletter
Ophthalmologist Urges Early Intervention in Dry Eye Management to Avoid Surprises
Jason Bacharach, MD, of North Bay Eye Associates in northern California, has a word of advice for ophthalmologists and optometrists. Four words, actually: interventional dry eye management (IDEM). ...
9/22/2026
DiagnosticEuropeIOLMicroscopesNewsletterRegulation
Alcon Launches Unity M Ophthalmic Surgical Microscope
Alcon announced Sept. 3 the initial commercial launch of its Unity M ophthalmic surgical microscope. The company said the microscope, which has received CE marking in Europe and regulatory approval...
9/22/2026
DeviceDry EyeGlaucomaMyopiaNewsletterRegulation
Select US FDA Approvals and Clearances in August 2026
The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in August 2026, according to the agency’s database. Sight Sciences received clearance for a label...
9/22/2026
NewsletterPresbyopiaRetinaThyroid Eye Disease
PDUFA Dates for Ophthalmic Drug Candidates, September 2026
The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) and Biosimilar User Fee Act (BsUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.